September 17, 2024 Guidance from international committee on differential diagnoses and diagnostic approach Approximately 85% of cases of multiple sclerosis…

The BTK inhibitor tolebrutinib meets its primary endpoint in phase 3 HERCULES trial For the first time, a medication has…

September 19, 2024 By Valentin Krüger, MD / Isabella Ciccone, MPH — Fact checked by Marco Meglio The neurology resident at the…

Sep 18, 2024 East Hanover, September 18, 2024 – Novartis today announced new data from the ALITHIOS open-label extension study. Data…

Feeling fatigued? Take a look at how multiple sclerosis can affect your sleep and the actions you can take today…

Ocrevus Zunovo™ has the potential to expand treatment options to centers without IV infrastructure or with IV constraints, like at a…

Multiple sclerosis (MS)  affects everyone differently. If you or your loved one has MS, you are probably familiar with symptoms such…

Photography by Julia Forsman/Stocksy United Letting your loved ones know about your symptoms, triggers, and boundaries can help them better…

An Empowered Spirit Blog Post – Written by Cathy Chester on September 9, 2024 A decade ago, I wrote a blog post about…

If you’ve recently received a diagnosis of multiple sclerosis (MS), you may feel overwhelmed, sad, angry, shocked, in disbelief, or…